AEHR Test Systems buy BiotechBee
Start price
03.09.23
/
70%
€48.70
Target price
30.09.25
€60.00
Performance (%)
-54.17%
End price
02.12.23
€22.32
Summary
This prediction ended on 02.12.23 with a price of €22.32. Massive losses of -54.17% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AEHR Test Systems | -3.189% | -3.189% | 275.735% |
| iShares Core DAX® | -6.016% | -4.595% | 1.284% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.401% |
| iShares Nikkei 225® | -7.156% | -2.215% | 27.886% |
| iShares S&P 500 | -0.257% | -0.841% | 10.254% |
According to BiotechBee what are the pros and cons of AEHR Test Systems for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aehr Test Systems diskutieren
Buy mit Kursziel 60,0